Wilsey Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.5M Buy
1,390,058
+202,641
+17% +$5.3M 4.92% 13
2026
Q1
$33.3M Sell
1,187,417
-7,978
-0.7% -$212K 5.23% 12
2025
Q4
$29.8M Buy
1,195,395
+91,852
+8% +$2.32M 4.62% 13
2025
Q3
$28.1M Buy
1,103,543
+118,248
+12% +$2.92M 5.16% 12
2025
Q2
$23.9M Buy
985,295
+43,566
+5% +$1.02M 4.4% 14
2025
Q1
$23.9M Buy
941,729
+58,372
+7% +$1.53M 4.78% 14
2024
Q4
$23.4M Buy
883,357
+57,572
+7% +$1.56M 4.34% 14
2024
Q3
$23.9M Buy
825,785
+2,521
+0.3% +$73.5K 4.38% 16
2024
Q2
$23M Buy
823,264
+201,418
+32% +$5.55M 4.84% 12
2024
Q1
$17.3M Buy
621,846
+36,767
+6% +$1.02M 3.52% 14
2023
Q4
$16.8M Buy
585,079
+17,231
+3% +$521K 3.44% 16
2023
Q3
$18.8M Buy
+567,848
New +$20.1M 4.27% 13
2015
Q1
Sell
-65,851
Closed -$1.95M 23
2014
Q4
$1.95M Buy
65,851
+229
+0.3% +$6.57K 1.36% 22
2014
Q3
$1.84M Sell
65,622
-1,542
-2% -$43.3K 1.47% 20
2014
Q2
$1.89M Sell
67,164
-1,171
-2% -$33.4K 1.47% 21
2014
Q1
$2.08M Buy
68,335
+1,653
+2% +$49.3K 1.68% 20
2013
Q4
$1.93M Buy
+66,682
New +$1.94M 1.77% 20

Other funds holding PFE

Wilsey Asset Management's PFE Position: Q2 2026 in Review

Wilsey Asset Management increased its Pfizer (PFE) stake by 17% in Q2 2026, buying an estimated $5.3M and bringing the position to 1,390,058 shares worth $33.5M. The position accounts for 4.92% of the portfolio, ranked #13.

Wilsey Asset Management first reported a position in PFE in Q4 2013 and has held it in 17 quarters since. 1,309 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Wilsey Asset Management held 1,390,058 shares of Pfizer worth $33.5M as of Q2 2026.
  • Wilsey Asset Management bought 202,641 Pfizer shares in Q2 2026, an estimated $5.3M.
  • Pfizer made up 4.92% of Wilsey Asset Management's portfolio in Q2 2026, its #13 holding.
  • Wilsey Asset Management first reported a position in Pfizer in Q4 2013 and has held it in 17 quarters since.
  • 1,309 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wilsey Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.